A clinical study of an Ayurvedic formulation with and without Nidana Parivarjana in the management of Vyanabala Vaishamya w.s.r. to primary hypertension

ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients willing to sign the consent form for the clinical trial.
•2. Patients belonging to either sex between the age group 18 to 59 years.
•3. Patients having no known complication of disease.
•4. Diagnosed case of stage-1 (Systolic B.P 140 to 159, Diastolic B.P 90 to 99 mm of Hg) would be selected for study (as per 8thJNC).

•1. Patients having secondary hypertension.
•2. Patents having systemic/serious complications of Cardiovascular / Cerebrovascular / Renal system.
•3. Pregnant patients.
•4. Patients on Oral Contraceptive Pills.
•5. History of liver disease in the recent past.
•6. Hypertensive-Retinopathy
•7. Patients who have completed participation in any other clinical trial drugs or their ingredients within one month period.
•8. Patients who have received any Antihypertensive medication (Modern Drug) within last two weeks.

发起方

ational Institute of Ayurveda Jaipur